Medication cost for treatment of metabolic dysregulation decreases following adolescent bariatric surgery
- PMID: 40571792
- DOI: 10.1007/s00464-025-11920-0
Medication cost for treatment of metabolic dysregulation decreases following adolescent bariatric surgery
Abstract
Background: The burden of obesity-related metabolic dysfunction in adolescents is skyrocketing; the purpose of this study is to understand the impact of adolescent bariatric surgery on the utilization and cost of medications for treatment of metabolic dysregulation.
Methods: Using the MarketScan database of commercial health insurance claims from 2011-2019, bariatric surgery patients ages 14-18 (n = 992) were assessed for patterns of medication utilization pre-surgery (beginning of MarketScan enrollment to 6 months before surgery) and post-surgery (> 12 months after surgery). We examined the cost and rate of prescription fills for diabetes, cardiovascular, and dyslipidemia medications. We calculated standardized utilization rates and ran generalized estimating equations for utilization and cost of each medication with Poisson distribution to test for differences at the various time intervals. We also compared utilization and cost for the surgical patients two three control groups, stratified based on body mass index.
Results: Utilization of diabetes and dyslipidemia medications showed a significant decrease in the incidence rate ratio (95% confidence interval) for the post-surgery period relative to the pre-surgery period (0.428 (0.223-0.82) p = 0.01; 0.194 (0.056-0.667) p < 0.01). The total annual cost for the entire cohort of bariatric surgery patients (95% confidence interval) also decreased after surgery with dyslipidemia medications decreasing by $8,666.11 ($1011.84-$16,308.48), cardiovascular medications decreasing by $33,890.68 ($14,403.84-$53,389.44) and diabetes medications decreasing by $45,949.44 ($3,083.14-$94,993.92).
Conclusion: Following adolescent bariatric surgery, there is a decrease in utilization of diabetes and dyslipidemia medications. There was decreased cost for diabetes, dyslipidemia, and cardiovascular medications. These results suggest that performing bariatric surgery during late adolescence is associated with overall improvements in metabolic health.
Keywords: Adolescent bariatric surgery; Medication costs; Metabolic dysregulation.
© 2025. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Conflict of interest statement
Declarations. Conflict of interest: Drs. Alexander, Wilcox, Horns, Wallace, Russell and Mr. Das have no disclosures to report relevant to this manuscript. Dr. Ibele is funded by the NIH (U01 CA272529), which is unrelated to the content of this manuscript.
Similar articles
-
The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation.Health Technol Assess. 2009 Sep;13(41):1-190, 215-357, iii-iv. doi: 10.3310/hta13410. Health Technol Assess. 2009. PMID: 19726018
-
Discontinuation of blood pressure-lowering, glucose-lowering, and lipid-lowering medications after bariatric surgery in patients with morbid obesity: a nationwide cohort study in South Korea.Surg Obes Relat Dis. 2024 Sep;20(9):840-848. doi: 10.1016/j.soard.2024.03.008. Epub 2024 Mar 15. Surg Obes Relat Dis. 2024. PMID: 38631926
-
Surgery for the treatment of obesity in children and adolescents.Cochrane Database Syst Rev. 2022 Sep 8;9(9):CD011740. doi: 10.1002/14651858.CD011740.pub2. Cochrane Database Syst Rev. 2022. PMID: 36074911 Free PMC article.
-
Hybrid closed-loop systems for managing blood glucose levels in type 1 diabetes: a systematic review and economic modelling.Health Technol Assess. 2024 Dec;28(80):1-190. doi: 10.3310/JYPL3536. Health Technol Assess. 2024. PMID: 39673446 Free PMC article.
-
Impact of poor medication adherence on clinical outcomes and health resource utilization in patients with hypertension and/or dyslipidemia: systematic review.Expert Rev Pharmacoecon Outcomes Res. 2024 Jan;24(1):143-154. doi: 10.1080/14737167.2023.2266135. Epub 2024 Jan 18. Expert Rev Pharmacoecon Outcomes Res. 2024. PMID: 37862440
References
-
- Srivastava G (2024) Bariatric surgery in adolescents-a vital treatment option. Transl Pediatr 13(8):1287–1289. https://doi.org/10.21037/tp-24-160 - DOI - PubMed - PMC
-
- Bolling CF, Armstrong SC, Reichard KW, Michalsky MP; Section on Obesity, Section on Surgery (2019) Metabolic and bariatric surgery for pediatric patients with severe obesity. Pediatrics 144(6):e20193224. https://doi.org/10.1542/peds.2019-3224 - DOI - PubMed
-
- Inge TH, Courcoulas AP, Jenkins TM, Michalsky MP, Helmrath MA, Brandt ML, Harmon CM, Zeller MH, Chen MK, Xanthakos SA, Horlick M, Buncher CR, for the Teen-LABS Consortium (2016) Weight loss and health status 3 years after bariatric surgery in adolescents. New Eng J Med 374(2):113–123. https://doi.org/10.1056/NEJMoa1506699 - DOI - PubMed
-
- Vuong L, Chang SH, Wan F, Wu N, Eagon JC, Eckhouse SR, Dimou FM (2022) National trends and outcomes in adolescents undergoing bariatric surgery. J Am Coll Surg 235(2):186–194. https://doi.org/10.1097/XCS.0000000000000234 - DOI - PubMed
-
- Stanford Center for Population Health Sciences (2023) MarketScan Databases (Version 3.0). [Data set]
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous